No abstract available
MeSH terms
-
COVID-19*
-
Diabetes Mellitus, Type 2* / diagnosis
-
Diabetes Mellitus, Type 2* / drug therapy
-
Diabetes Mellitus, Type 2* / epidemiology
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Longevity
-
Metformin* / adverse effects
-
Neoplasms* / drug therapy
-
Neoplasms* / epidemiology
Substances
-
Metformin
-
Hypoglycemic Agents